Pharma's Almanac TV
PA TV
Follow the Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Research
CDMO
CRO
Excipients
Pharmaceutical Equipment
Pharmaceutical Intermediates
Supply Chain Logistics
Magazine
Current Issue
Archive
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
By The Numbers
Biologics
155 Articles Available
1
7
Can't find what you're looking for? Try our
advanced search
.
Leadership
A CEO’s Perspective: Positioning a CDMO for Significant Growth
PAP-Q3-20-CL-008
Clinical Supply
Getting Your Biologic to Clinic Faster and More Efficiently
PAP-Q3-20-CL-011
Nice Insight Overview
Drug Approval Trends: Significant Acceleration in Recent Years
PAP-Q2-20-NI-001
GSK's Asthma Biologic Approved
PR-M04-20-NI-007
Facility
WuXi Biologics Completes Weather-Tight Seal of its Biologics Manufacturing Facility in Ireland
PR-M03-20-NI-019
Biologics
FDA and FTC Announce New Efforts to Further Deter Anti-Competitive Business Practices, Support Competitive Market for Biological Products
PR-M02-20-NI-016
Analytical Development
Solving Process Challenges Requires Flexibility to Explore Alternative Analytical Methods
PAP-Q4-19-CL-017
Bispecific Antibody
Challenges of Manufacturing the Expanding Range of Bi/Multispecific Modalities
PAP-Q4-19-CL-022
Strategic Partnership
Partnering for Success from Concept to Commercialization
PAP-Q4-19-CL-010
Drug Delivery
LEO Pharma and Portal Instruments Announce Collaboration to Develop Needle-Free Drug Delivery Device
PR-M12-19-NI-007
Expression Systems
Choosing the Right Expression Platform for Biologics
PAP-Q3-19-NI-005
Customer Centricity
Achieving Rapid Success with a Flexible, Client-Centric Approach
PAP-Q3-19-CL-024
Biologics
Northway Biotechpharma Celebrates 15 Years of Growth and Success
PAP-Q3-19-CL-019
Biologics Manufacturing
Flexible Biologics Manufacturing in Lithuiana
PTV-M08-19-BIO-010
Expansion
WuXi Biologics to Expand Integrated Biologics Conjugation Solution Center to Include Commercial Manufacturing
PR-M06-19-NI-054
Biological Materials
Keys to Successful Storage, Management and Transport of Biological Materials
PAP-Q2-2019-CL-035
Expansion
Polpharma Biologics: Building on Early Achievements
PAP-Q2-2019-CL-027
Customer Focus
Designing a Customer-Centric CDMO
PAP-Q2-2019-CL-003
Capacity Expansion
Biotechpharma to Expand Process Development and GMP Manufacturing Capacity to 5,000 L
PR-M04-19-NI-057
Formulation
Developing and Characterizing DPI Formulations for Biologics
PAP-Q1-2019-CL-002
Lifecycle Support
Speed and Customized Support from Gene to GMP Manufacturing
PAP-Q1-2019-CL-026
Financing
Entrada Therapeutics Raises $59 Million Series A to Advance Intracellular Biologics Platform
PR-M12-18-NI-081
Biologics
Rentschler Expands Capabilities in Biologics Contract Manufacturing
PR-M12-18-NI-012
Biologics Manufacturing
AGC Triples U.S. Biopharmaceutical Production Capacity
PR-M12-18-NI-066
1
7
»
